Donepezil Hydrochloride; Memantine Hydrochloride Capsule, Extended Release shortage
To Be Discontinued 2 presentations · 1 manufacturers · first FDA posting Jun 15, 2026 · last update Jun 15, 2026
Manufacturers: Amneal Pharmaceuticals
Stated reasons (per FDA): Not stated
More info: FDA Drug Shortages Database · ASHP drug shortages list (search there for this drug)
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Donepezil Hydrochloride; Memantine Hydrochloride, Capsule, Extended Release, 10 mg; 28 mg (NDC 69238-1247-3) | Amneal Pharmaceuticals | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted Jun 15, 2026 Updated Jun 15, 2026 Discontinued Jun 15, 2026 |
| Donepezil Hydrochloride; Memantine Hydrochloride, Capsule, Extended Release, 10 mg; 14 mg (NDC 69238-1248-3) | Amneal Pharmaceuticals | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted Jun 15, 2026 Updated Jun 15, 2026 Discontinued Jun 15, 2026 |